期刊文献+
共找到1,207篇文章
< 1 2 61 >
每页显示 20 50 100
以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效 被引量:45
1
作者 董家鸿 项灿宏 +5 位作者 石军 曾建平 汤睿 王学栋 李昂 张洪义 《中华消化外科杂志》 CAS CSCD 北大核心 2017年第10期1053-1060,共8页
目的探讨以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效。方法采用回顾性描述性研究方法。收集2014年12月至2016年6月清华大学附属清华长庚医院收治的4例不同Bismuth分型肝门部胆管癌患者的临床病理资料。经术前检查和评估后... 目的探讨以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效。方法采用回顾性描述性研究方法。收集2014年12月至2016年6月清华大学附属清华长庚医院收治的4例不同Bismuth分型肝门部胆管癌患者的临床病理资料。经术前检查和评估后制订对应的手术策略,患者行单独围肝门切除术或围肝门切除联合中央区域肝段切除术。观察指标:(1)术中情况。(2)术后病理学检查结果。(3)术后情况。(4)随访情况。采用门诊方式进行随访,随访内容为:腹痛、发热等一般状况,血常规和肿瘤标志物检查,影像学检查判断肿瘤有无复发和转移。随访时间截至2017年6月。计量资料以平均数(范围)表示。结果(1)术中情况:4例患者均顺利完成手术,平均手术时间为512min(300~620min);采用持续门静脉阻断的人肝血流阻断方式,平均阻断时间为70min(57~80min);平均术中出血量为537mL(200~1000mL);2例术中分别输注2U血浆、4U血浆+4URBC。(2)术后病理学检查结果:4例患者术后病理学检查结果显示:肿瘤大小分别为1.5cm×1.2cm×1.1cm、1.3cm×1.1cm×1.0cm、2.0cm×1.7cm×1.5cm、2.0cm×2.0cm×1.5cm;肿瘤分化程度:1例为中分化胆管腺癌,3例为低分化胆管腺癌。4例患者肝门区的神经侵犯均为阳性,3例淋巴结转移阳性。4例患者均为R0切除。4例患者TNM分期:1例T2aN1M0期,3例T2bN1M0期。(3)术后情况:4例患者中,1例术后发生胆汁漏,经保守治疗后痊愈,术后第67天出院;3例术后恢复顺利,并于术后21、14、14d出院。术后未进行放化疗等辅助治疗。(4)随访情况:4例患者均获得随访,随访时间为12—31个月,随访期间患者一般状况均良好,1例发生一过性发热,经保守治疗后缓解。4例患者肿瘤标志物均在正常范围内,增强CT检查结果显示无肿瘤 展开更多
关键词 胆管肿瘤 肝门部 围肝门切除 段肝管
原文传递
Prognostic factors and long-term outcomes of hilar cholangiocarcinoma:A single-institution experience in China 被引量:41
2
作者 Hai-Jie Hu Hui Mao +6 位作者 Anuj Shrestha Yong-Qiong Tan Wen-Jie Ma Qin Yang Jun-Ke Wang Nan-Sheng Cheng Fu-Yu Li 《World Journal of Gastroenterology》 SCIE CAS 2016年第8期2601-2610,共10页
AIM: To evaluate the prognostic factors of hilar cholangiocarcinoma in a large series of patients in a single institution.METHODS: Eight hundred and fourteen patients with a diagnosis of hilar cholangiocarcinoma that ... AIM: To evaluate the prognostic factors of hilar cholangiocarcinoma in a large series of patients in a single institution.METHODS: Eight hundred and fourteen patients with a diagnosis of hilar cholangiocarcinoma that were evaluated and treated between 1990 and 2014, of which 381 patients underwent curative surgery, were included in this study. Potential factors associated with overall survival(OS) and disease-free survival(DFS) were evaluated by univariate and multivariate analyses.RESULTS: Curative surgery provided the best long-term survival with a median OS of 26.3 mo. The median DFS was 18.1 mo. Multivariate analysis showed that patients with tumor size > 3 cm [hazard ratio(HR) = 1.482, 95%CI: 1.127-1.949; P = 0.005], positive nodal disease(HR = 1.701, 95%CI: 1.346-2.149; P < 0.001), poor differentiation(HR = 2.535, 95%CI: 1.839-3.493; P < 0.001), vascular invasion(HR = 1.542, 95%CI: 1.082-2.197; P = 0.017), and positive margins(HR = 1.798, 95%CI: 1.314-2.461; P < 0.001) had poor OS outcome. The independent factors for DFS were positive nodal disease(HR = 3.383, 95%CI: 2.633-4.348; P < 0.001), poor differentiation(HR = 2.774, 95%CI: 2.012-3.823; P < 0.001), vascular invasion(HR = 2.136, 95%CI: 1.658-3.236; P < 0.001), and positive margins(HR = 1.835, 95%CI: 1.256-2.679; P < 0.001). Multiple logistic regression analysis showed that caudate lobectomy [odds ratio(OR) = 9.771, 95%CI: 4.672-20.433; P < 0.001], tumor diameter(OR = 3.772, 95%CI: 1.914-7.434; P < 0.001), surgical procedures(OR = 10.236, 95%CI: 4.738-22.116; P < 0.001), American Joint Committee On Cancer T stage(OR = 2.010, 95%CI: 1.043-3.870; P = 0.037), and vascular invasion(OR = 2.278, 95%CI: 0.997-5.207; P = 0.051) were independently associated with tumorfree margin, and surgical procedures could indirectly affect survival outcome by influencing the tumor resection margin. CONCLUSION: Tumor margin, tumor differentiation, vascular invasion, and lymph node status were independent factors for OS and DFS. Surgical procedures can indirectly affect surv 展开更多
关键词 hilar CHOLANGIOCARCINOMA Prognosis SURGICAL OUTCOME Survival Tumor-free MARGIN
下载PDF
精准医学时代肝门部胆管癌的治疗 被引量:43
3
作者 陈孝平 项帅 《中华消化外科杂志》 CAS CSCD 北大核心 2018年第1期3-8,共6页
由于肝门部胆管癌的解剖位置特殊,其生长方式具有纵向浸润和横向侵犯的特点,单纯手术切除难以获得满意的疗效。越来越多的学者认识到肝门部胆管癌的治疗还要充分考虑肿瘤的生物学性状。精准医学利用医学前沿技术和蛋白质组、基因组等... 由于肝门部胆管癌的解剖位置特殊,其生长方式具有纵向浸润和横向侵犯的特点,单纯手术切除难以获得满意的疗效。越来越多的学者认识到肝门部胆管癌的治疗还要充分考虑肿瘤的生物学性状。精准医学利用医学前沿技术和蛋白质组、基因组等组学技术,在分子水平对疾病进行精准诊断,可能为肝门部胆管癌的治疗提供新的模式。 肝门部胆管癌基因突变率较高,最常见的突变基因为KRAS和TP53,其他突变率较高的基因还有CDKN2A、SMAD4、ERBB2、PTEN、APIK3CA、ARID1A、MLL3、ROBO2、RNF43、PEG3和GNAS等。如此频繁的重要功能性基因突变提示肝门部胆管癌可能包含分子靶向药物的潜在治疗靶点。然而由于胆管癌发病机理复杂,多数靶向治疗的临床药物研究尚未能取得突破性进展。综合治疗仍应以手术切除为主。需要个体化地确定合适的肝切除范围,多数病人行小范围肝切除术即可达到根治目的。 展开更多
关键词 胆管肿瘤 肝门部 精准医学 靶向治疗 肝切除术
原文传递
322例肝门部胆管癌的临床疗效及预后因素分析 被引量:42
4
作者 隋鑫磊 汤恢焕 +9 位作者 肖广发 陆晔斌 何群 周军 魏伟 梁帅 黄耿文 孙维佳 李宜雄 龚学军 《中华消化外科杂志》 CAS CSCD 北大核心 2017年第4期391-397,共7页
目的探讨肝门部胆管癌的临床疗效及影响预后的因素。方法采用回顾性病例对照研究方法。收集2005年12月至2015年11月中南大学湘雅医院收治的322例肝门部胆管癌患者的临床病理资料。患者行实验室检查和影像学检查,根据检查结果进行术前... 目的探讨肝门部胆管癌的临床疗效及影响预后的因素。方法采用回顾性病例对照研究方法。收集2005年12月至2015年11月中南大学湘雅医院收治的322例肝门部胆管癌患者的临床病理资料。患者行实验室检查和影像学检查,根据检查结果进行术前肿瘤分期、分型并制订治疗方案。观察指标:(1)临床表现及辅助检查结果。(2)治疗及病理学检查结果。(3)随访和生存情况。(4)预后因素分析:性别、年龄、术前最高血清TBil、术前CEA、术前CA19—9、术前CA242、术前CA125、治疗方法、TNM分期。采用门诊及电话方式进行随访,以患者死亡为终点.了解患者生存情况。随访时间截至2016年11月。采用Kaplan—Meier法绘制生存曲线,Log—rank检验进行生存分析及单因素分析,COX比例风险回归模型进行多因素分析。结果(1)临床表现及辅助检查结果:322例患者中,301例以黄疸为主诉。322例患者术前最高血清TBil水平为3.9~785.2μmol/L,DSil为1.6~410.2μmol/L,ALT为14.8~484.5U/L,AST为21.4~539.8U/L;272例检测ALP、GGT,其水平分别为93.8-1890.0U/L、2.0~1832.8U/L;292例检测CEA,升高者77例:298例检测CA19—9,升高者272例;260例检测CA242、CA125,升高者分别为153、86例。322例患者根据Bismuth-Cor]ette分型:I型24例、Ⅱ型115例、Ⅲa型55例、Ⅲb型63例、Ⅳ型65例。(2)治疗及病理学检查结果:322例患者中,104例行根治性切除术,其中围肝门胆管切除术79例(联合血管切除重建术9例),扩大肝叶切除术25例(联合肝尾状叶切除术16例);218例行姑息治疗,其中胆道外引流术134例,胆肠内引流术84例。围术期死亡5例,其中2例急性肝衰竭,1例全身感染、多器官衰竭,1例急性肾衰竭,1例急性化脓性胆管炎、感染性休克、全身弥散性血管内凝血。263例患者行病理学 展开更多
关键词 胆道肿瘤 肝门部 疗效 预后因素
原文传递
Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome 被引量:37
5
作者 SD Mansfield O Barakat +4 位作者 RM Charnley BC Jaques CB O'Suilleabhain PJ Atherton D Manas 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第48期7625-7630,共6页
AIM: To assess the management and outcome of hilar cholangiocarcinoma (Klatskin tumor) in a single tertiary referral center.METHODS: The notes of all patients with a diagnosis of hilar cholangiocarcinoma referred to o... AIM: To assess the management and outcome of hilar cholangiocarcinoma (Klatskin tumor) in a single tertiary referral center.METHODS: The notes of all patients with a diagnosis of hilar cholangiocarcinoma referred to our unit for over an 8-year period were identified and retrospectively reviewed. Presentation, management and outcome were assessed.RESULTS: Seventy-five patients were identified. The median age was 64 years (range 34-84 years). Male to female ratio was 1:1. Eighty-nine percent of patients presented with jaundice. Most patients referred were under Bismuth classification 3a, 3b or 4. Seventy patients required biliary drainage, 65 patients required 152percutaneous drainage procedures, and 25 had other complications. Forty-one patients had 51 endoscopic drainage procedures performed (15 failed). Of these,36 subsequently required percutaneous drainage. The median number of drainage procedures for all patients was three, 18 patients underwent resection (24%), nine had major complications and three died post-operatively.The 5-year survival rate was 4.2% for all patients, 21%for resected patients and 0% for those who did not undergo resection (P = 0.0021). The median number of admissions after diagnosis in resected patients was two and three in non-resected patients (P<0.05).Twelve patients had external-beam radiotherapy, seven brachytherapy, and eight chemotherapy. There was no significant benefit in terms of survival (P = 0.46) or hospital admissions.CONCLUSION: Resection increases survival but carries the risk of significant morbidity and mortality.Percutaneous biliary drainage is almost always necessary and endoscopic drainage should be avoided if possible. 展开更多
关键词 hilar cholangiocarcinoma PATHOLOGY TREATMENT OUTCOME ENGLAND
下载PDF
Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy 被引量:34
6
作者 Jun-Jie Xiong Quentin M Nunes +4 位作者 Wei Huang Samir Pathak Ai-Lin Wei Chun-Lu Tan Xu-Bao Liu 《World Journal of Gastroenterology》 SCIE CAS 2013年第46期8731-8739,共9页
AIM:To investigate the effect of preoperative biliary drainage(PBD)in jaundiced patients with hilar cholangiocarcinoma(HCCA)undergoing major liver resections.METHODS:An observational study was carried out by reviewing... AIM:To investigate the effect of preoperative biliary drainage(PBD)in jaundiced patients with hilar cholangiocarcinoma(HCCA)undergoing major liver resections.METHODS:An observational study was carried out by reviewing a prospectively maintained database of HCCA patients who underwent major liver resection for curative therapy from January 2002 to December 2012.Patients were divided into two groups based on whether PBD was performed:a drained group and an undrained group.Patient baseline characteristics,preoperative factors,perioperative and short-term postoperative outcomes were compared between the two groups.Risk factors for postoperative complications were also analyzed by logistic regression test with calculating OR and 95%CI.RESULTS:In total,78 jaundiced patients with HCCA underwent major liver resection:32 had PBD prior to operation while 46 did not have PBD.The two groups were comparable with respect to age,sex,body mass index and co-morbidities.Furthermore,there was no significant difference in the total bilirubin(TBIL)levels between the drained group and the undrained group at admission(294.2±135.7 vs 254.0±63.5,P=0.126).PBD significantly improved liver function,reducing not only the bilirubin levels but also other liver enzymes.The preoperative TBIL level was significantly lower in the drained group as compared to the undrained group(108.1±60.6 vs 265.7±69.1,P=0.000).The rate of overall postoperative complications(53.1%vs 58.7%,P=0.626),reoperation rate(6.3%vs 6.5%,P=1.000),postoperative hospital stay(16.5 vs 15.0,P=0.221)and mortality(9.4%vs 4.3%,P=0.673)were similar between the two groups.In addition,there was no significant difference in infectious complications(40.6%vs 23.9%,P=0.116)and noninfectious complications(31.3%vs 47.8%,P=0.143)between the two groups.Univariate and multivariate analyses revealed that preoperative TBIL>170μmol/L(OR=13.690,95%CI:1.275-147.028,P=0.031),Bismuth-Corlette classification(OR=0.013,95%CI:0.001-0.166,P=0.001)and extended liver resection(OR=14.010,95%CI:1.130-173. 展开更多
关键词 OBSTRUCTIVE JAUNDICE hilar cholangiocar-cinoma PREOPERATIVE BILIARY drainage Major hepatec-tomy Surgical OUTCOME
下载PDF
肝门部胆管癌手术切除的远期疗效及预后因素分析 被引量:36
7
作者 殷晓煜 刘鑫 +5 位作者 陈伟 蔡建鹏 陈东 张昆松 赖佳明 梁力建 《中华消化外科杂志》 CAS CSCD 北大核心 2016年第4期329-333,共5页
目的探讨肝门部胆管癌手术切除的远期疗效及其影响预后的因素。方法采用回顾性病例对照研究方法。收集2007年1月至2014年8月中山大学附属第一医院收治的129例行手术切除肝门部胆管癌患者的临床病理资料。采用门诊及电话方式进行随访,... 目的探讨肝门部胆管癌手术切除的远期疗效及其影响预后的因素。方法采用回顾性病例对照研究方法。收集2007年1月至2014年8月中山大学附属第一医院收治的129例行手术切除肝门部胆管癌患者的临床病理资料。采用门诊及电话方式进行随访,观察患者生存情况,肿瘤复发、转移情况。随访时间截至2015年10月。观察指标:(1)患者远期疗效(1、3、5年生存率,生存时间)。(2)预后因素分析指标:患者性别、年龄、术前CA19-9、肿瘤直径、肿瘤根治程度(R0或R0切除)、血管切除重建、改良T分期、淋巴结转移、TNM分期、肿瘤分化程度。(3)对独立预后因素进行分层分析。采用Kaplan-Meier法绘制生存曲线,Log-rank检验进行生存分析。采用Ⅳ。检验进行单因素分析,采用COX回归模型进行多因素分析。结果(1)129例患者中,4例于围术期死亡。112例患者获得随访,随访时间为1~98个月,中位随访时间为19个月。随访期间,75例患者死亡。129例患者总体中位生存时间为23个月,1、3、5年生存率分别为71.1%、31.4%、14.6%。(2)单因素分析结果显示:肿瘤根治程度、改良T分期、淋巴结转移、TNM分期、肿瘤分化程度是影响行手术切除肝门部胆管癌患者预后的相关因素(x2=5.566,5.450,4.558,4.033,6.093,P〈0.05)。多因素分析结果显示:肿瘤根治程度为R1切除、TNM分期为Ⅲ~Ⅳ期、肿瘤分化程度为低分化是影响行手术切除肝门部胆管癌患者预后不良的独立危险因素(HR=2.328,1.691,1.750,95%可信区间:1.224~4.427,1.035~2.762,1.205~2.542,P〈0.05)。(3)110例R0切除患者中位生存时间为24个月,1、3、5年生存率分别为75.5%、36.0%、15.8%;19例R1切除患者中位生存时间为12个月,1、3年生存率分别为47.1%、7.1%,5年生存� 展开更多
关键词 胆道肿瘤 肝门部 手术切除 预后因素
原文传递
Retrospective cohort study Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma 被引量:30
8
作者 Kazumichi Kawakubo Hiroshi Kawakami +11 位作者 Masaki Kuwatani Shin Haba Taiki Kudo Yoko A Taya Shuhei Kawahata Yoshimasa Kubota Kimitoshi Kubo Kazunori Eto Nobuyuki Ehira Hiroaki Yamato Manabu Onodera Naoya Sakamoto 《World Journal of Gastrointestinal Endoscopy》 CAS 2016年第9期385-390,共6页
AIM:To identify the most effective endoscopic biliary drainage technique for patients with hilar cholangiocarcinoma.METHODS:In total,118 patients with hilar cholangiocarcinoma underwent endoscopic management[endoscopi... AIM:To identify the most effective endoscopic biliary drainage technique for patients with hilar cholangiocarcinoma.METHODS:In total,118 patients with hilar cholangiocarcinoma underwent endoscopic management[endoscopic nasobiliary drainage(ENBD)or endoscopic biliary stenting]as a temporary drainage in our institution between 2009 and 2014.We retrospectively evaluated all complications from initial endoscopic drainage to surgery or palliative treatment.The risk factors for biliary reintervention,post-endoscopic retrograde cholangiopancreatography(post-ERCP)pancreatitis,and percutaneous transhepatic biliary drainage(PTBD)were also analyzed using patient-and procedure-related characteristics.The risk factors for bilateral drainage were examined in a subgroup analysis of patients who underwent initial unilateral drainage.RESULTS:In total,137 complications were observed in92(78%)patients.Biliary reintervention was required in 83(70%)patients.ENBD was significantly associated with a low risk of biliary reintervention[odds ratio(OR)=0.26,95%CI:0.08-0.76,P=0.012].Post-ERCP pancreatitis was observed in 19(16%)patients.An absence of endoscopic sphincterotomy was significantly associated with post-ERCP pancreatitis(OR=3.46,95%CI:1.19-10.87,P=0.023).PTBD was required in 16(14%)patients,and Bismuth type III or IV cholangiocarcinoma was a significant risk factor(OR=7.88,95%CI:1.33-155.0,P=0.010).Of 102 patients with initial unilateral drainage,49(48%)required bilateral drainage.Endoscopic sphincterotomy(OR=3.24,95%CI:1.27-8.78,P=0.004)and Bismuth II,III,or IV cholangiocarcinoma(OR=34.69,95%CI:4.88-736.7,P<0.001)were significant risk factors for bilateral drainage.CONCLUSION:The endoscopic management of hilar cholangiocarcinoma is challenging.ENBD should be selected as a temporary drainage method because of its low risk of complications. 展开更多
关键词 hilar CHOLANGIOCARCINOMA ENDOSCOPIC nasobiliary drainage ENDOSCOPIC biliary STENTING ENDOSCOPIC SPHINCTEROTOMY COMPLICATIONS
下载PDF
肝门部胆管癌多学科团队的诊断与治疗 被引量:32
9
作者 梁廷波 白雪莉 《中华消化外科杂志》 CAS CSCD 北大核心 2015年第4期268-274,共7页
肝门部胆管癌因手术难度大、根治性切除率低成为困扰肝胆外科的一大难题.随着临床医师对该病认识的加深、医学技术的进步,尤其是近年来多学科团队(MDT)诊断与治疗模式的兴起,肝门部胆管癌的诊断与治疗得到不断改进和优化.笔者从肝门... 肝门部胆管癌因手术难度大、根治性切除率低成为困扰肝胆外科的一大难题.随着临床医师对该病认识的加深、医学技术的进步,尤其是近年来多学科团队(MDT)诊断与治疗模式的兴起,肝门部胆管癌的诊断与治疗得到不断改进和优化.笔者从肝门部胆管癌的诊断技术、主要分型分期系统、术前可切除性评估方法、根治术及肝移植应用、各种系统疗法的地位等方面阐述MDT在其治疗中的应用.鉴于肝门部胆管癌的复杂性,以外科为中心的MDT密切合作尤为必要和重要. 展开更多
关键词 胆道肿瘤 肝门部 多学科团队 诊断 治疗
原文传递
肝门部胆管癌10年外科治疗经验 被引量:30
10
作者 姜小清 易滨 +5 位作者 罗祥基 刘辰 谭蔚锋 程庆保 张柏和 吴孟超 《中华消化外科杂志》 CAS CSCD 2010年第3期180-182,共3页
目的总结肝门部胆管癌单个治疗组10年外科治疗的经验。方法回顾性分析2000年1月至2009年12月第二军医大学东方肝胆外科医院收治的1572例肝门部胆管癌患者中,单个治疗组收治的462例患者的临床资料。其中手术治疗314例,非手术治疗148例... 目的总结肝门部胆管癌单个治疗组10年外科治疗的经验。方法回顾性分析2000年1月至2009年12月第二军医大学东方肝胆外科医院收治的1572例肝门部胆管癌患者中,单个治疗组收治的462例患者的临床资料。其中手术治疗314例,非手术治疗148例。对可能影响预后的因素采用Kaplan—Meier生存分析、Log—rank检验以及Cox回归模型分析,不同因素间相关性分析采用x^2检验。结果314例行手术治疗的患者中,237例切除肿瘤,其中Rn切除174例、R,切除17例、R2切除46例。91例患者出现各种术后并发症,10例患者术后院内死亡。260例患者获得随访,总体1、3、5年生存率分别为71.7%、32.6%和10.9%;R0切除患者1、3、5年生存率分别为76.9%、48.6%和32.7%,中位生存时间为35个月。R。切除、TNM分期、区域淋巴结转移、肿瘤分化程度是预后的独立影响因素(RR=2.1,1.9,2.2,1.7,P〈0.05)。结论根治性切除仍然是肝门部胆管癌治愈的首选方法,术前系统性评估和准备可以提高根治切除率并减少手术并发症。 展开更多
关键词 胆管肿瘤 肝门 外科手术 治疗 预后
原文传递
肝门部胆管癌手术方式的正确选择 被引量:30
11
作者 彭承宏 程坤 《中华消化外科杂志》 CAS CSCD 北大核心 2012年第1期11-14,共4页
肝门部胆管癌由Klatskin在1965年首次描述,是指发生在左肝管、右肝管、左右肝管分叉部和肝总管上段的胆管黏膜上皮恶性肿瘤。其发病率近30年来有增加趋势,占胆道肿瘤的67%,多数患者预后差,术后5年的生存率〈30%,根治性R0切除是... 肝门部胆管癌由Klatskin在1965年首次描述,是指发生在左肝管、右肝管、左右肝管分叉部和肝总管上段的胆管黏膜上皮恶性肿瘤。其发病率近30年来有增加趋势,占胆道肿瘤的67%,多数患者预后差,术后5年的生存率〈30%,根治性R0切除是目前惟一可能获得治愈或提高长期生存率的方法。由于肝门部胆管癌解剖的复杂性以及肿瘤本身具有肝转移、淋巴结转移、周围血管侵犯及神经浸润的生物学特性,其手术治疗仍然颇为棘手。 展开更多
关键词 胆管肿瘤 肝门部 肝切除术 外科手术
原文传递
三维重建虚拟手术规划在肝门部胆管癌手术中的应用价值 被引量:26
12
作者 林科灿 曾永毅 +3 位作者 黎蕴通 罗顺峰 曾金华 刘景丰 《中华消化外科杂志》 CAS CSCD 北大核心 2018年第4期383-388,共6页
目的:探讨三维重建虚拟手术规划在肝门部胆管癌手术中的应用价值。方法:采用回顾性横断面研究方法。收集2014年1月至2017年9月福建医科大学附属第一医院收治的36例肝门部胆管癌患者的临床病理资料。术前应用IQQA-Liver系统对CT检查图... 目的:探讨三维重建虚拟手术规划在肝门部胆管癌手术中的应用价值。方法:采用回顾性横断面研究方法。收集2014年1月至2017年9月福建医科大学附属第一医院收治的36例肝门部胆管癌患者的临床病理资料。术前应用IQQA-Liver系统对CT检查图像进行三维可视化重建及虚拟手术规划,基于虚拟手术规划结果结合术中具体实际情况行精准肿瘤切除术。观察指标:(1)虚拟手术规划情况。(2)手术及术后情况。(3)随访和生存情况。采用门诊和电话方式进行随访,了解患者术后生存及肿瘤复发、转移情况。随访时间截至2017年11月。正态分布的计量资料以±s表示,术前虚拟手术规划指标与实际手术指标比较采用t检验。采用Kaplan-Meier法计算术后生存时间。结果:(1)虚拟手术规划情况:36例患者均完成三维重建及虚拟手术规划。三维重建结果可清楚显示肿瘤大小、与周围血管及胆管空间毗邻关系。36例患者经三维重建虚拟手术规划评估肿瘤Bismuth-Corlette分型为Ⅱ型2例、Ⅲa型13例、Ⅲb型14例、Ⅳ型7例,肿瘤体积为(76±26)mL,全肝体积为(1 319±306)mL,预切除肝脏体积为(588±128)mL,剩余肝脏体积为(731±269)mL。(2)手术及术后情况:36例患者中,16 例行左半肝切除术,12例行右半肝切除术,5例行扩大左半肝切除术,3例行扩大右半肝切除术;36例患者均联合行肝尾状叶切除术;1例联合行肝动脉切除重建术,2例联合行门静脉楔形切除修补术,1例联合行门静脉切除后端端吻合术。36例患者手术时间为(368±134)min,术中出血量为(474±288)mL。36例患者中,3例发生术后肺部感染,3例发生腹腔感染,2例发生腹腔淋巴液漏,均经保守治疗后痊愈。36例患者术后住院时间为(19±7)d。36例患者术后肿瘤Bismuth-Corlette分型为:Ⅱ型2例、Ⅲa型11例、Ⅲb型13 展开更多
关键词 胆管肿瘤 肝门部 肝门部胆管癌 外科手术 三维重建 虚拟手术 可视化 精准肝脏外科
原文传递
Laparoscopic liver resection under hemihepatic vascular inflow occlusion using the lowering of hilar plate approach 被引量:24
13
作者 Ying-Jun Chen Zuo-Jun Zhen +4 位作者 Huan-Wei Chen Eric CH Lai Fei-Wen Deng Qing-Han Li Wan Yee Lau 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2014年第5期508-512,共5页
BACKGROUND: With advances in technology, laparoscopic liver resection is widely accepted. Laparoscopic liver resection under hemihepatic vascular inflow occlusion has advantages over the conventional total hepatic in... BACKGROUND: With advances in technology, laparoscopic liver resection is widely accepted. Laparoscopic liver resection under hemihepatic vascular inflow occlusion has advantages over the conventional total hepatic inflow occlusion using the Pringle's maneuver, especially in patients with cirrhosis.METHOD: From November 2011 to August 2012, eight consecutive patients underwent laparoscopic liver resection under hemihepatic vascular inflow occlusion using the lowering of hilar plate approach with biliary bougie assistance.RESULTS: The types of liver resection included right hepatectomy(n1), right posterior sectionectomy(n1), left hepatectomy and common bile duct exploration(n1), segment 4b resection(n1), left lateral sectionectomy(n2), and wedge resection(n2). Four patients underwent right and 4 left hemihepatic vascular inflow occlusion. Four patients had cirrhosis. The mean operation time was 176.3 minutes. The mean time taken to achieve hemihepatic vascular inflow occlusion was 24.3minutes. The mean duration of vascular inflow occlusion was54.5 minutes. The mean intraoperative blood loss was 361 mL.No patient required blood transfusion. Postoperatively, one patient developed bile leak which healed with conservative treatment. No postoperative liver failure and mortality occurred. The mean hospital stay of the patients was 7 days.CONCLUSION: Our technique of hemihepatic vascular inflow vascular occlusion using the lowering of hilar plate approachwas safe, and it improved laparoscopic liver resection by minimizing blood loss during liver parenchymal transection. 展开更多
关键词 laparoscopic liver resection hepatectomy vascular control liver neoplasm hilar plate
下载PDF
Risk factors and classifications of hilar cholangiocarcinoma 被引量:24
14
作者 Miguel Angel Suarez-Munoz Jose Luis Fernandez-Aguilar +5 位作者 Belinda Sanchez-Perez Jose Antonio Perez-Daga Beatriz Garcia-Albiach Ysabel Pulido-Roa Naiara Marin-Camero Julio Santoyo-Santoyo 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2013年第7期132-138,共7页
Cholangiocarcinoma is the second most common primary malignant tumor of the liver.Perihilar cholangiocarcinoma or Klatskin tumor represents more than 50% of all biliary tract cholangiocarcinomas.A wide range of risk f... Cholangiocarcinoma is the second most common primary malignant tumor of the liver.Perihilar cholangiocarcinoma or Klatskin tumor represents more than 50% of all biliary tract cholangiocarcinomas.A wide range of risk factors have been identified among patients with Perihilar cholangiocarcinoma including advanced age,male gender,primary sclerosing cholangitis,choledochal cysts,cholelithiasis,cholecystitis,parasitic infection(Opisthorchis viverrini and Clonorchis sinensis),inflammatory bowel disease,alcoholic cirrhosis,nonalcoholic cirrhosis,chronic pancreatitis and metabolic syndrome.Various classifications have been used to describe the pathologic and radiologic appearance of cholangiocarcinoma.The three systems most commonly used to evaluate Perihilar cholangiocarcinoma are the Bismuth-Corlette(BC) system,the Memorial Sloan-Kettering Cancer Center and the TNM classification.The BC classification provides preoperative assessment of local spread.The Memorial Sloan-Kettering cancer center proposes a staging system according to three factors related to local tumor extent:the location and extent of bile duct involvement,the presence or absence of portal venous invasion,and the presence or absence of hepatic lobar atrophy.The TNM classification,besides the usual descriptors,tumor,node and metastases,provides additional information concerning the possibility for the residual tumor(R) and the histological grade(G).Recently,in 2011,a new consensus classification for the Perihilar cholangiocarcinoma had been published.The consensus was organised by the European Hepato-PancreatoBiliary Association which identified the need for a new staging system for this type of tumors.The classification includes information concerning biliary or vascular(portal or arterial) involvement,lymph node status or metastases,but also other essential aspects related to the surgical risk,such as remnant hepatic volume or the possibility of underlying disease. 展开更多
关键词 hilar CHOLANGIOCARCINOMA Klatskin TUMOR Perihilar CHOLANGIOCARCINOMA BILE DUCT cancer
下载PDF
Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma 被引量:24
15
作者 Hiroyuki Isayama Takeshi Tsujino +5 位作者 Yousuke Nakai Takashi Sasaki Keiichi Nakagawa Hideomi Yamashita Taku Aoki Kazuhiko Koike 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第19期2364-2370,共7页
AIM: To determine the efficacy of external beam radiotherapy (EBRT), with or without intraluminal brachytherapy (ILBT), in patients with non-resected locally advanced hilar cholangiocarcinoma.METHODS: We analyze... AIM: To determine the efficacy of external beam radiotherapy (EBRT), with or without intraluminal brachytherapy (ILBT), in patients with non-resected locally advanced hilar cholangiocarcinoma.METHODS: We analyzed 64 patients with locally advanced hilar cholangiocarcinoma, including 25 who underwent resection (17 curative and 8 non-curative), 28 treated with radiotherapy, and 11 who received best supportive care (BSC). The radiotherapy group received EBRT (50 Gy, 30 fractions), with 11 receiving an ad- ditional 24 Gy (4 fractions) ILBT by iridium-192 with remote after loading. ILBT was performed using percu-taneous transhepatic biliary drainage (PTBD) route. Uncovered metallic stents (UMS) were inserted into nonresected patients with obstructive jaundice, with the exception of four patients who received percutaneous transhepatic biliary drainage only. UMS were placed endoscopically or percutaneously, depending on the initial drainage procedure. The primary endpoints were patient death or stent occlusion. Survival time of patients in the radiotherapy group was compared with that of patients in the resection and BSC groups. Stent patency was compared in the radiotherapy and BSC groups.RESULTS: No statistically significant differences in patient characteristics were found among the resection, radiotherapy, and BSC groups. Three patients in the radiotherapy group and one in the BSC group did not receive UMS insertion but received PTBD alone; cholangitis occurred after endoscopic stenting, and patients were treated with PTBD. A total of 16 patients were administered additional systemic chemotherapy (5-fluorouracil-based regimen in 9, S-1 in 6, and gemcitabine in 1). Overall survival varied significantly among groups, with median survival times of 48.7 mo in the surgery group, 22.1 mo in the radiotherapy group, and 5.7 mo in the BSC group. Patients who underwent curative resection survived significantly longer than those who were not candidates for surgery (P = 0.0076). Cumu 展开更多
关键词 hilar cholangiocarcinoma RADIOTHERAPY Intra-luminal brachytherapy Biliary metallic stent Ob-structive jaundice
下载PDF
Hilar cholangiocarcinoma:preoperative evaluation with a three dimensional volumetric interpolated breath-hold examination magnetic resonance imaging sequence 被引量:21
16
作者 YIN Long-lin SONG Bin XU Juan LI Ying-chun 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第8期636-642,共7页
Background Early detection and accurate staging are crucial for planning treatment and improving survival rate of hilar cholangiocarcinomas. This study investigated the diagnostic value of a three dimensional, spoiled... Background Early detection and accurate staging are crucial for planning treatment and improving survival rate of hilar cholangiocarcinomas. This study investigated the diagnostic value of a three dimensional, spoiled gradient echo, Tl-weighted magnetic resonance (MR) imaging sequence (3D volumetric interpolated breath-hold examination, 3D-VIBE) in the preoperative evaluation of hilar cholangiocarcinoma. Methods Thirty-one patients with surgically and histologically confirmed hilar cholangiocarcinomas underwent preoperative MR imaging examination. Unenhanced two-dimensional T1- and T2-weighted images, 2D MR cholangiopancreatographs (MRCP), gadolinium enhanced 3D-VIBE images in the early arterial, late arterial and portal venous phases followed by 2D Tl-weighted images in the equilibrium phase were acquired. Images from 3D-VIBE, 2D T1-weighted enhanced sequences and 2D MRCP were interpreted by two abdominal radiologists through consensus reading in blind manner, focussing on the assessment of the morphological type, the longitudinal extent of tumor infiltration in the bile ducts and the involvement of neighbouring blood vessels. The accuracy of 3D-VIBE and 2D T1-weighted enhanced sequences in assessing the tumor resectability was compared. Results All the 31 tumors were directly displayed and accurately classified on 3D-VIBE images whereas 8 periductal infiltrating tumors (8/31, 25.8%) were not depicted on 2D T1-weighted enhanced images. Using the Bismuth Corlette classification, 3D-VIBE was closer to MRCP in delineating the intraductal extent of tumor infiltration than 2D T1-weighted enhanced (28/31, 90.3%; 10/31, 32.3%; x^2=22.0, P〈0.05). Involvement of the hepatic artery, the portal venous trunk and their branches was shown more frequently on 3D VIBE than 2D T1-weighted enhanced images. The positive predictive value and accuracy of 3D-VIBE (84.2%; 90.3%) for assessing tumor resectability were higher than those of 2D T1-weighted enhanced images (64.0%; 71.0%, all P〈0.05). Conclusi 展开更多
关键词 CHOLANGIOCARCINOMA hilar dynamic imaging magnetic resonance imaging
原文传递
肝门部胆管癌外科治疗25年的历程 被引量:22
17
作者 黄志强 《中华消化外科杂志》 CAS CSCD 2010年第3期161-164,共4页
1989年,国内首次报道肝门部胆管癌以来,该病的治疗作为跨世纪的热点问题已逐渐深入。但是,存在的争议仍然较多,距最后解决问题仍有差距。
关键词 胆管肿瘤 肝门 外科手术 治疗
原文传递
肝门部胆管癌 被引量:23
18
作者 黄志强 《中华消化外科杂志》 CAS CSCD 北大核心 2013年第3期166-169,共4页
肝门部胆管癌是指位于胆囊管开口以上的肝总管,左、右肝管汇合部和左、右肝管的胆管黏膜上皮癌。由于肝门部特殊的解剖学位置及肝门部胆管癌生物学特性,其极易早期侵犯肝门区血管、神经、淋巴结组织及邻近肝组织,因此,手术难度大,... 肝门部胆管癌是指位于胆囊管开口以上的肝总管,左、右肝管汇合部和左、右肝管的胆管黏膜上皮癌。由于肝门部特殊的解剖学位置及肝门部胆管癌生物学特性,其极易早期侵犯肝门区血管、神经、淋巴结组织及邻近肝组织,因此,手术难度大,患者预后差。在现代影像学指导下的扩大肝切除术可能给这个凶险的疾病予以希望。但国内外学者就扩大肝切除术存在诸多争议,目前尚无统一的标准。因此,肝门部胆管癌外科治疗亟待规范化,以提高其根治性切除率,减少手术相关并发症发生率和病死率。 展开更多
关键词 胆管肿瘤 肝门 肝切除术 预后
原文传递
Endobronchial Ultrasound Elastography for Diagnosing Mediastinal and Hilar Lymph Nodes 被引量:20
19
作者 Hai-Yan He Mao Huang +2 位作者 Jie Zhu Hang Ma Xue-Dong Lyu 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第20期2720-2725,共6页
Background: Pathophysiological processes, such as malignancy, can lead to the formation of stiffer tissue in lung cancers. Endobronchial ultrasound rEBUS) elastography is a novel technique for measuring tissue stiff... Background: Pathophysiological processes, such as malignancy, can lead to the formation of stiffer tissue in lung cancers. Endobronchial ultrasound rEBUS) elastography is a novel technique for measuring tissue stiffness during EBUS-guided transbronchial needle aspiration (EBUS-TBNA). The current study was conducted to investigate the diagnostic value of EBUS elastography tbr mediastinal and hilar lymph node metastasis in lung cancers. Methods: From January 2014 to January 2015, 40 patients suspected of lung cancer were enrolled, and a total of 68 lymph nodes were evaluated by EBUS-TBNA. EBUS-guided elastography of lymph nodes was perfornaed prior to EBUS-TBNA. Standard EBUS characteristics were also described. Pathological determination of malignant or benign lymph nodes was used as the gold standard for this study. If EBUS-TBNA did not result in a tbrmal pathological diagnosis of malignancy, patients were referred for a surgical procedure. Comparisons of elastography and standard EBUS characteristics were made between benign and malignant lymph nodes. Results: Elastography grading scores and strain ratios showed significant differences between benign and malignant lymph nodes (P = 0.000). The elastography strain ratio was more sensitive and specific for determining malignant lymph nodes than elastography grading score or standard EBUS criteria. The receiver operating characteristic curve for the elastography strain ratio showed an area under the curve of 0.933. The best cut-off point of the strain ratio for differentiating malignant from benign lymph nodes was 32.07. The elastography strain ratio had a sensitivity of 88.1%, the specificity of 80.8%, positive predictive value of 88.1%, and negative predictive value of 80.8% for distinguishing malignant from benign nodes. The overall accuracy of elastography strain ratio was 85.3%. The strain ratio of malignant and benign lymph nodes positively correlated with the elastography grading score (r = 0.561, P = 0.000). Conclusions: EBUS elastograp 展开更多
关键词 ELASTOGRAPHY Endobronchial Ultrasound Lung Cancer Mediastinal and hilar Lymph Node Strain Ratio
原文传递
Laparoscopy in the management of hilar cholangiocarcinoma 被引量:18
20
作者 Akihiro Cho Hiroshi Yamamoto +4 位作者 Osamu Kainuma Yorihiko Muto Hiroo Yanagibashi Toru Tonooka Takahito Masuda 《World Journal of Gastroenterology》 SCIE CAS 2014年第41期15153-15157,共5页
The use of minimally invasive surgery has become widely accepted in many gastrointestinal fields,even in patients with malignancy.However,performing laparoscopic resection for the treatment of hilar cholangiocarcinoma... The use of minimally invasive surgery has become widely accepted in many gastrointestinal fields,even in patients with malignancy.However,performing laparoscopic resection for the treatment of hilar cholangiocarcinoma is still not universally accepted as an alternative approach to open surgery,and only a limited number of such procedures have been reporteddue to the difficulty of performing oncologic resection and the lack of consensus regarding the adequacy of this approach.Laparoscopy was initially limited to staging,biopsy and palliation.Recent technological developments and improvements in endoscopic procedures have greatly expanded the applications of laparoscopic liver resection and lymphadenectomy,and some reports have described the use of laparoscopic or robot-assisted laparoscopic resection for hilar cholangiocarcinoma as being feasible and safe in highly selected cases,with the ability to obtain an adequate surgical margin.However,the benefits of major laparoscopic surgery have yet to be conclusively proven,and carefully selecting patients is essential for successfully performing this procedure. 展开更多
关键词 hilar cholangiocarcinoma LAPAROSCOPY Minimally invasive surgery
下载PDF
上一页 1 2 61 下一页 到第
使用帮助 返回顶部